SIBUTRAMIN

SIBUTRAMIN 5 mg: Sibutramine hydrochloride monohydrate 5 mg.

SIBUTRAMIN 10 mg: Sibutramine hydrochloride monohydrate 10 mg.

SIBUTRAMIN 15 mg: Sibutramine hydrochloride monohydrate 15 mg.

Pharmaceutical form: capsule.
Therapeutic category: management of obesity.

Composition:

SIBUTRAMIN 5 mg: Each capsule contains: Sibutramine hydrochloride monohydrate

5 mg.

SIBUTRAMIN 10 mg: Each capsule contains: Sibutramine hydrochloride

monohydrate 10 mg.

SIBUTRAMIN 15 mg: Each capsule contains: Sibutramine hydrochloride

monohydrate 15 mg.

 

Indications:

SIBUTRAMIN is indicated for the management of obesity, and should be used in

conjunction with a reduced calorie diet. SIBUTRAMIN is recommended for obese

patients with an initial body mass index ≥ 30Kg/m2, or ≥27 Kg/m2 in the presence

of other risk factors (e.g., hypertension, diabetes, dyslipidemia).

 

Dosage and administration:

The recommended starting dose of SIBUTRAMIN is 10 mg administered once daily

with or without food.

If there is inadequate weight loss, the dose may be titrated after four weeks to a

total 15 mg once daily.

The 5 mg dose should be reserved for patients who do not tolerate the 10 mg

dose.

 
 
Home Page | About Us |  Products |  Facilities | Policies | Contact Us | Site Map